{"id":3102,"date":"2023-09-28T05:00:56","date_gmt":"2023-09-28T10:00:56","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=3102"},"modified":"2023-09-25T12:11:48","modified_gmt":"2023-09-25T17:11:48","slug":"fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/","title":{"rendered":"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-3105 size-full\" src=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg\" alt=\"woman-698964_1280-e1695661666719\" width=\"400\" height=\"597\" srcset=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg 400w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719-201x300.jpg 201w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719-80x120.jpg 80w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/>Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus Congestion. It was believed that the drug worked to reduce blood vessel swelling in the nasal passages, and that this got rid of congestion. These decongestants generated nearly $1.8 billion in sales in 2022. A Food and Drug Administration (FDA) <a href=\"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-clarifies-results-recent-advisory-committee-meeting-oral-phenylephrine\" target=\"_blank\" rel=\"noopener\">advisory panel<\/a> has advised that data shows over-the-counter cold and allergy medications that contain phenylephrine don\u2019t effectively eliminate nasal congestion. A unanimous vote by the panel declared that the drug is not useful.<\/p>\n<p><strong>Call Moll Law Group About Dangerous Drug Claims<\/strong><\/p>\n<p>The FDA only started to review over-the-counter cold medicines in 1976. Over the last 30 years, Florida pharmacy professors have pressured the FDA to do something about the efficacy of phenylephrine. Back in 1993, Dr. Leslie Hendeles wrote a paper published in a medical journal that phenylephrine didn\u2019t work because it was destroyed in the stomach and never made it to the bloodstream. Further research over the years determined the drug was not any better than a placebo. Pandemic legislation changes FDA staffing and procedures so that they\u2019re more in line with the rules surrounding prescription drugs, and this caused the FDA to produce an 89-page review.<\/p>\n<p>While the FDA makes final decisions about drugs, they sometimes use advisory committees to give them advice and recommendations. FDA considers a committee\u2019s advice and recommendations when deciding; in this case the advisory committee\u2019s opinion was based on the FDA\u2019s 89-page review.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#more-3102\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus Congestion. It was believed that the drug worked to reduce blood vessel swelling in the nasal passages, and that this got rid of congestion. These decongestants generated nearly $1.8 billion in sales in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3105,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-3102","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; September 28, 2023<\/title>\n<meta name=\"description\" content=\"Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus &#8212; September 28, 2023\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; September 28, 2023\" \/>\n<meta name=\"twitter:description\" content=\"Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus &#8212; September 28, 2023\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; September 28, 2023","description":"Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus &#8212; September 28, 2023","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/","twitter_card":"summary_large_image","twitter_title":"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; September 28, 2023","twitter_description":"Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus &#8212; September 28, 2023","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion","datePublished":"2023-09-28T10:00:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/"},"wordCount":583,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg","articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/","url":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/","name":"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; September 28, 2023","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg","datePublished":"2023-09-28T10:00:56+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus &#8212; September 28, 2023","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg","width":400,"height":597},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-advisory-panel-determines-that-phenylephrine-doesnt-get-rid-of-congestion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA Advisory Panel Determines that Phenylephrine Doesn\u2019t Get Rid of Congestion"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/09\/woman-698964_1280-e1695661666719.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=3102"}],"version-history":[{"count":3,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3102\/revisions"}],"predecessor-version":[{"id":3106,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3102\/revisions\/3106"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/3105"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=3102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=3102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=3102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}